https://www.orthoworld.com
ORTHOWORLD
Late-Quarter Infuse Headwinds Blunt Medtronic’s Growth
By Mike Evers
Medtronic’s FY3Q20 growth was surprisingly light due to headwinds around Infuse orders, but the enabling technology continues to drive implant sales.